Sep 17, 2026 07:30AM
Sep 17, 2026 07:30AM
Sep 15, 2026 08:01AM
Sep 15, 2026 08:00AM
Aug 20, 2026 08:00AM
Aug 20, 2026 08:00AM
Aug 6, 2026 07:31AM Nuvation Bio posts $31.7M Q2 revenue, widens net loss to $62.8M
Aug 6, 2026 07:30AM
Aug 4, 2026 08:01AM
Aug 4, 2026 08:00AM
Jun 29, 2026 08:01AM
Jun 29, 2026 08:00AM
May 27, 2026 08:00AM
May 27, 2026 08:00AM Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
May 13, 2026 04:05PM
May 13, 2026 04:05PM
May 6, 2026 08:01AM
May 6, 2026 08:00AM
May 4, 2026 04:10PM
Apr 27, 2026 08:00AM
Apr 21, 2026 06:00PM Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
Apr 1, 2026 08:01AM
Apr 1, 2026 08:00AM
Mar 27, 2026 08:50AM
Mar 27, 2026 06:46AM
Mar 26, 2026 04:05PM
Mar 26, 2026 04:05PM
Mar 17, 2026 04:35PM Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
Mar 2, 2026 04:05PM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM
Feb 4, 2026 06:50AM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM
Jan 12, 2026 07:33AM Nuvation Bio partners with Eisai for taletrectinib in Europe
Jan 12, 2026 07:30AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM
Nov 24, 2025 07:33AM
Nov 19, 2025 01:02AM
Nov 3, 2025 04:05PM
Oct 23, 2025 07:31AM Nuvation Bio begins phase 3 trial of safusidenib for brain cancer
Oct 23, 2025 07:30AM
Sep 30, 2025 07:30AM
Sep 30, 2025 07:30AM
Sep 30, 2025 02:04AM
Sep 19, 2025 07:30AM
Sep 19, 2025 07:30AM
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 7, 2025 06:00AM

331,677 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All